Annual SGA
$10.93 M
-$1.72 M-13.59%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual SGA is $10.93 million, with the most recent change of -$1.72 million (-13.59%) on December 31, 2023.
- During the last 3 years, EFTR annual SGA has risen by +$6.58 million (+151.21%).
- EFTR annual SGA is now -18.29% below its all-time high of $13.37 million, reached on December 31, 2021.
Performance
EFTR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.09 M
+$566.00 K+22.42%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly SGA is $3.09 million, with the most recent change of +$566.00 thousand (+22.42%) on March 31, 2024.
- Over the past year, EFTR quarterly SGA has increased by +$163.00 thousand (+5.57%).
- EFTR quarterly SGA is now -51.10% below its all-time high of $6.32 million, reached on December 31, 2021.
Performance
EFTR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$699.78 M
-$34.63 M-5.21%
March 31, 2024
Summary
- As of February 8, 2025, EFTR TTM SGA is -$699.78 million, with the most recent change of -$34.63 million (-5.21%) on March 31, 2024.
- Over the past year, EFTR TTM SGA has dropped by -$711.91 million (-5867.09%).
- EFTR TTM SGA is now -411.91% below its all-time high of -$136.70 million.
Performance
EFTR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
EFTR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.6% | +5.6% | -5867.1% |
| 3 y3 years | +151.2% | +5.6% | -5867.1% |
| 5 y5 years | +151.2% | +5.6% | -5867.1% |
EFTR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.3% | at low | -51.1% | +23.6% | -168.3% | at low |
| 5 y | 5-year | -18.3% | +151.2% | -51.1% | +191.5% | -411.9% | at low |
| alltime | all time | -18.3% | +151.2% | -51.1% | +191.5% | -411.9% | at low |
EFFECTOR Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $3.09 M(+22.4%) | $11.09 M(+1.5%) |
| Dec 2023 | $10.93 M(-13.6%) | $2.52 M(+1.0%) | $10.93 M(-2.0%) |
| Sep 2023 | - | $2.50 M(-15.9%) | $11.15 M(-8.1%) |
| Jun 2023 | - | $2.97 M(+1.6%) | $12.13 M(+0.0%) |
| Mar 2023 | - | $2.93 M(+6.5%) | $12.13 M(-4.0%) |
| Dec 2022 | $12.64 M | $2.75 M(-21.2%) | $12.64 M(-22.0%) |
| Sep 2022 | - | $3.49 M(+17.3%) | $16.21 M(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $2.97 M(-13.5%) | $16.85 M(+8.4%) |
| Mar 2022 | - | $3.44 M(-45.6%) | $15.54 M(+16.2%) |
| Dec 2021 | $13.37 M(+207.4%) | $6.32 M(+53.4%) | $13.37 M(+64.8%) |
| Sep 2021 | - | $4.12 M(+147.5%) | $8.11 M(+60.4%) |
| Jun 2021 | - | $1.66 M(+31.1%) | $5.06 M(+49.1%) |
| Mar 2021 | - | $1.27 M(+19.7%) | $3.39 M(+59.8%) |
| Dec 2020 | $4.35 M | $1.06 M(-0.3%) | $2.12 M(+99.7%) |
| Sep 2020 | - | $1.06 M | $1.06 M |
FAQ
- What is eFFECTOR Therapeutics annual SGA?
- What is the all time high annual SGA for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual SGA year-on-year change?
- What is eFFECTOR Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly SGA year-on-year change?
- What is eFFECTOR Therapeutics TTM SGA?
- What is the all time high TTM SGA for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics TTM SGA year-on-year change?
What is eFFECTOR Therapeutics annual SGA?
The current annual SGA of EFTR is $10.93 M
What is the all time high annual SGA for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual SGA is $13.37 M
What is eFFECTOR Therapeutics annual SGA year-on-year change?
Over the past year, EFTR annual SGA has changed by -$1.72 M (-13.59%)
What is eFFECTOR Therapeutics quarterly SGA?
The current quarterly SGA of EFTR is $3.09 M
What is the all time high quarterly SGA for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly SGA is $6.32 M
What is eFFECTOR Therapeutics quarterly SGA year-on-year change?
Over the past year, EFTR quarterly SGA has changed by +$163.00 K (+5.57%)
What is eFFECTOR Therapeutics TTM SGA?
The current TTM SGA of EFTR is -$699.78 M
What is the all time high TTM SGA for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high TTM SGA is -$136.70 M
What is eFFECTOR Therapeutics TTM SGA year-on-year change?
Over the past year, EFTR TTM SGA has changed by -$711.91 M (-5867.09%)